- Home
- » Tags
- » Aleglitazar
Top View
- Exposure and Response Analysis of Aleglitazar On
- Drugs in Pipeline for Type-2 Diabetes R Mahajan, K Gupta
- Insight Into Newer Anti-Diabetic Treatment
- Oral Antidiabetic Agents-Review and Updates 2 3 Patience O
- Roche's Long-Odds Aleglitazar Bet Points to Others Chasing the Cardio
- Novel Treatments for Type 2 Diabetes
- Past and Current Perspective on New Therapeutic Targets for Type-II Diabetes
- PPAR-Mediated Toxicology and Applied Pharmacology
- Exploration and Development of PPAR Modulators in Health and Disease : an Update of Clinical Evidence
- The Cardiovascular Effects of Peroxisome Proliferator- Activated Receptor Agonists Sayuri N
- Torino, Verdana, Aprile 04
- Supplementary Materials: Building and Testing Pparγ Therapeutic ELB00824 with an Improved Therapeutic Window for Neuropathic Pain
- Fibrates, Glitazones and Peroxisome Proliferator-Activated Receptors Fanny Lalloyer1,2,3,4 and Bart Staels1,2,3,4
- Profil Science Report 2014
- Science Report 2016
- Pleiotropic Effects of Glitazones: a Double Edge Sword?
- Current Molecular Pharmacology, 2019, 12, 195-201
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Recent Advances in Diabetes Mellitus
- Effects of Aleglitazar, a Balanced Dual Peroxisome Proliferator-Activated
- Effect of Aleglitazar on Cardiovascular Outcomes After Acute Coronary Syndrome in Patients with Type 2 Diabetes Mellitus the Alecardio Randomized Clinical Trial
- Aleglitazar Failure Will Have Little Impact on Booming Diabetes Market
- Wo 2010/045656 A2
- Ppars and Myocardial Infarction
- Effect of a Dual PPAR Α/Γ Agonist on Insulin Sensitivity in Patients Of
- Cooperative Cobinding of Synthetic and Natural Ligands to the Nuclear
- Top 10 Pipelines
- Saroglitazar
- New Drugs in Development for the Treatment of Diabetes
- Protocol Bc22419)
- Comparative Transcriptional Network Modeling of Three PPAR-#/# Co-Agonists Reveals Distinct Metabolic Gene Signatures in Primary Human Hepatocytes